🔍
Search Results - weiwei+he
6
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
The Efficacy of Nanozyme in Neurodegenerative Diseases
Unmet NeedOxidative stress and subsequent prion-like pathology is an essential driver n the pathogenesis of neurodegenerative diseases, including Parkinson’s Disease (PD and Alzheimer’s disease (AD). Currently, only symptomatic treatments are available, and there is a great unmet need to develop a cure. Technology OverviewDisclosed herein are novel...
Published: 3/14/2025
|
Inventor(s):
Xiaobo Mao
,
Shuya Li
,
Weiwei He
Keywords(s):
Category(s):
Clinical and Disease Specializations > Neurology > Alzheimer's Disease
,
Clinical and Disease Specializations > Neurology > Neurodegeneration
,
Clinical and Disease Specializations > Neurology > Parkinson's Disease
,
Clinical and Disease Specializations > Neurology > Parkinson’s Disease
,
Technology Classifications > Therapeutic Modalities > Proteins
PtCu Nanozyme Scavenging ROS for Prevention of Pathologic α-Synuclein Transmission
Description: Unmet Need Parkinson’s disease (PD) is the second most common neurodegenerative disorder characterized with misfolded α-synuclein (α-syn) accumulation in Lewy bodies (LB). Although some α-syn mutations have been associated with familial PD, the majority cases are sporadic with unknown etiology. Tremendous efforts have been made to develop...
Published: 3/14/2025
|
Inventor(s):
Xiaobo Mao
,
Weiwei He
,
Yuqing Liu
Keywords(s):
Category(s):
Clinical and Disease Specializations > Neurology
,
Clinical and Disease Specializations > Neurology > Neurodegeneration
,
Technology Classifications > Therapeutic Modalities
,
Technology Classifications > Therapeutic Modalities > Dendrimers & Polymers
HIV-1 Latency Cell Line Construction
Unmet NeedApproximately 38 million people are currently living with human immunodeficiency virus (HIV) globally. HIV is a serious health issue, and around 1 million people die from HIV/AIDS related illnesses each year. Currently, there is no cure for HIV, only prevention and treatment techniques exist. Current methods of treatment use antiretroviral...
Published: 3/14/2025
|
Inventor(s):
Robert Siliciano
,
Weiwei Dai
Keywords(s):
Category(s):
Clinical and Disease Specializations > Infectious Diseases > Covid-19
,
Technology Classifications > Research Tools > Cell Lines
Identification of Novel Coumestan Derivatives as Pks13 Inhibitors against Mycobacterium Tuberculosis
Unmet NeedTuberculosis (TB) is an infectious disease caused by the bacteria Mycobacterium tuberculosis (Mtb), which typically impacts the lungs. In 2016, there were 10.4 million new cases of TB and 1.7 million deaths worldwide, with approximately one-fourth of the world’s population infected. As a result, TB is one of the leading infectious disease...
Published: 3/14/2025
|
Inventor(s):
William Bishai
,
Shichun Lun
,
Li-Fang Yu
,
Shu-Huan Wang
,
Fan Yang
,
Jie Tang
,
Hendra Gunosewoyo
,
Ashlee Earl
,
Abigail Manson
,
Wei Zhang
Keywords(s):
Antagonists/Inhibitors
,
Disease Indication
,
Infectious Diseases
,
Myobacterium Tuberculosis
,
Natural compounds
,
Non-novel
,
Predicted Novelty
,
Small Molecules
,
Therapeutic Matter
,
Therapeutic Substance
,
Therapeutics
,
Tuberculosis (TB)
Category(s):
Technology Classifications > Therapeutic Modalities > Small Molecules
,
Clinical and Disease Specializations > Infectious Diseases > Tuberculosis (TB)
Hypoxia-inducible factor reporter cell lines
Unmet NeedLow oxygen levels are a characteristic of many types of solid tumors. High levels of HIF1α, the transcription factor responsible for energy utilization under hypoxic conditions, has been implicated in tumor growth and resistance, angiogenesis, and poor patient prognosis. For these reasons, HIF1α remains an attractive target for novel cancer...
Published: 3/14/2025
|
Inventor(s):
Peter Espenshade
,
Wei Shao
Keywords(s):
Basic Research Biomarker
,
Cell Lines
,
Discovery/Research Tools
,
In Vitro Research Tool
,
Mouse Cell Lines
Category(s):
Technology Classifications > Research Tools > Cell Lines
Itraconazole Analogs and Use Thereof
C11669: Novel Compounds for Cancer and Macular Degeneration TreatmentNovelty: This invention is a series of novel and potent itraconazole derivative that have showed strong activity against tumor growth and macular degeneration.Value Proposition: The novel compounds effectively inhibit angiogenesis, which is critical for tumor growth and macular degeneration....
Published: 3/13/2025
|
Inventor(s):
Jun Liu
,
Wei Shi
,
Kalyan Kumar Pasunooti
,
Wukun Liu
,
Ruojing Li
,
Sarah Head
,
Yingjun Li
Keywords(s):
Antagonists/Inhibitors
,
Cancers
,
Disease Indication
,
Eye Disorders
,
Macular Degeneration
,
Novel
,
Predicted Novelty
,
Small Molecules
,
Therapeutic Matter
,
Therapeutic Substance
,
Therapeutics
Category(s):
Clinical and Disease Specializations
,
Clinical and Disease Specializations > Oncology
,
Technology Classifications > Therapeutic Modalities > Small Molecules
,
Technology Classifications > Therapeutic Modalities
,
Clinical and Disease Specializations > Ophthalmology > Macular Degeneration
JHTV Home
|
Search
|
Login/Subscribe
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by
Inteum